在 SARS-CoV-2（COVID-19）紧急情况下预防耳毒性。
Ototoxicity prevention during the SARS-CoV-2 (COVID-19) emergency.
机构信息
ENT & Audiology Department, University Hospital of Ferrara, Cona, Italy.
Institute of Physiology and Pathology of Hearing, Warsaw, Poland; Department of Heart Failure and Cardiac Rehabilitation, Medical University of Warsaw, Warsaw, Poland; Institute of Sensory Organs, Kajetany, Poland.
出版信息
J Glob Antimicrob Resist. 2020 Dec;23:263-264. doi: 10.1016/j.jgar.2020.09.030. Epub 2020 Oct 17.
Abstract
Aim of this paper is to remind the risk of ototoxicity when using chloroquine and hydroxychloroquine, in particular as prophylactic agents against SARS-CoV-2, during the pandemic. Healthy subjects taking chloroquine and hydroxychloroquine as prophylactic agents against SARS-CoV-2, during the pandemic, should be screened periodically, at least by Otoacoustic Emissions (OAEs) in order to detect early manifestations of possible cochlear ototoxic damages.
摘要
本文旨在提醒在大流行期间使用氯喹和羟氯喹（尤其是作为预防 SARS-CoV-2 的药物）时存在耳毒性风险。在大流行期间，服用氯喹和羟氯喹作为预防 SARS-CoV-2 的药物的健康受试者应定期进行筛查，至少通过耳声发射（OAE）进行筛查，以便早期发现可能的耳蜗耳毒性损害的表现。
相似文献
1
Ototoxicity prevention during the SARS-CoV-2 (COVID-19) emergency.在 SARS-CoV-2（COVID-19）紧急情况下预防耳毒性。
J Glob Antimicrob Resist. 2020 Dec;23:263-264. doi: 10.1016/j.jgar.2020.09.030. Epub 2020 Oct 17.
2
A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease-19 (COVID-19).氯喹和羟氯喹在冠状病毒病-19（COVID-19）中的预防作用的系统评价。
Int J Rheum Dis. 2020 May;23(5):613-619. doi: 10.1111/1756-185X.13842. Epub 2020 Apr 27.
3
Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection.氯喹、羟氯喹和阿奇霉素用于治疗新型冠状病毒肺炎（SARS-CoV-2感染）时的安全性考量
CMAJ. 2020 Apr 27;192(17):E450-E453. doi: 10.1503/cmaj.200528. Epub 2020 Apr 8.
4
What makes (hydroxy)chloroquine ineffective against COVID-19: insights from cell biology.（羟）氯喹对抗 COVID-19 无效的原因：细胞生物学的见解。
J Mol Cell Biol. 2021 Jul 6;13(3):175-184. doi: 10.1093/jmcb/mjab016.
5
Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19.氯喹和羟氯喹用于治疗新型冠状病毒肺炎的安全性考量
Clin Microbiol Infect. 2020 Sep;26(9):1276-1277. doi: 10.1016/j.cmi.2020.05.006. Epub 2020 May 16.
6
7
Chloroquine and hydroxychloroquine in covid-19.氯喹和羟氯喹在2019冠状病毒病中的应用
BMJ. 2020 Apr 8;369:m1432. doi: 10.1136/bmj.m1432.
8
Don't forget ototoxicity during the SARS-CoV-2 (Covid-19) pandemic!在 SARS-CoV-2（新冠病毒）大流行期间勿忘耳毒性！
Int J Immunopathol Pharmacol. 2020 Jan-Dec;34:2058738420941754. doi: 10.1177/2058738420941754.
9
Chloroquine and its derivatives in the management of COVID-19: A scoping review.氯喹及其衍生物在COVID-19治疗中的应用：一项范围综述。
Biomedica. 2020 Oct 30;40(Supl. 2):80-95. doi: 10.7705/biomedica.5478.
10
Of chloroquine and COVID-19.关于氯喹和 COVID-19。
Antiviral Res. 2020 May;177:104762. doi: 10.1016/j.antiviral.2020.104762. Epub 2020 Mar 5.
引用本文的文献
1
Adverse Audio-Vestibular Effects of Drugs and Vaccines Used in the Treatment and Prevention of COVID-19: A Review.用于治疗和预防新冠肺炎的药物及疫苗的不良听觉前庭效应：综述
Audiol Res. 2022 Apr 29;12(3):224-248. doi: 10.3390/audiolres12030025.
2
Detecting Novel Ototoxins and Potentiation of Ototoxicity by Disease Settings.通过疾病状态检测新型耳毒素及耳毒性的增强作用。
Front Neurol. 2021 Aug 17;12:725566. doi: 10.3389/fneur.2021.725566. eCollection 2021.
3
The Impact of COVID-19 and the Pandemic on Tinnitus: A Systematic Review.新型冠状病毒肺炎及大流行对耳鸣的影响：一项系统综述
J Clin Med. 2021 Jun 23;10(13):2763. doi: 10.3390/jcm10132763.
4
SARS-CoV-2 (COVID-19) and audio-vestibular disorders.严重急性呼吸综合征冠状病毒2（新冠病毒）与听觉前庭障碍
Int J Immunopathol Pharmacol. 2021 Jan-Dec;35:20587384211027373. doi: 10.1177/20587384211027373.
本文引用的文献
1
Hydroxychloroquine as Prophylaxis for Coronavirus SARS-CoV-2 Infection: Review of the Ongoing Clinical Trials.羟氯喹作为新型冠状病毒SARS-CoV-2感染的预防用药：正在进行的临床试验综述
Arch Bronconeumol (Engl Ed). 2020 Sep;56(9):606-608. doi: 10.1016/j.arbr.2020.05.010. Epub 2020 Sep 14.
2
Chloroquine as a prophylactic agent against COVID-19?氯喹作为 COVID-19 的预防药物？
Int J Antimicrob Agents. 2020 Jun;55(6):105980. doi: 10.1016/j.ijantimicag.2020.105980. Epub 2020 Apr 12.
3
Looking beyond the audiogram in ototoxicity associated with platinum-based chemotherapy.超越与铂类化疗相关的耳毒性的听力学检查结果。
Cancer Chemother Pharmacol. 2020 Feb;85(2):245-250. doi: 10.1007/s00280-019-04012-z. Epub 2019 Dec 21.
4
Hydroxychloroquine ototoxicity in a patient with systemic lupus erythematosus.一名系统性红斑狼疮患者的羟氯喹耳毒性
An Bras Dermatol. 2018 Jun;93(3):469-470. doi: 10.1590/abd1806-4841.20187615.
5
Chloroquine ototoxicity.氯喹耳毒性。
Clin Rheumatol. 2007 Nov;26(11):1809-10. doi: 10.1007/s10067-007-0662-6. Epub 2007 Jun 27.
6
Ototoxic effects of cisplatin in a Sprague-Dawley rat animal model as revealed by ABR and transiently evoked otoacoustic emission measurements.通过听性脑干反应（ABR）和瞬态诱发耳声发射测量揭示顺铂在Sprague-Dawley大鼠动物模型中的耳毒性作用。
Hear Res. 2002 Aug;170(1-2):70-82. doi: 10.1016/s0378-5955(02)00453-7.
7
Hydroxychloroquine ototoxicity in a patient with rheumatoid arthritis.
Rheumatol Int. 2000;19(5):203-4. doi: 10.1007/s002960000054.
Zotero 插件